You have 9 free searches left this month | for more free features.

1,3 beta-D-glucan

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Uveitis Trial in Jakarta Pusat (Beta-1,3/1,6-D-Glucan Ganoderma lucidum, Placebos)

Recruiting
  • Uveitis
  • Beta-1,3/1,6-D-Glucan Ganoderma lucidum
  • Placebos
  • Jakarta Pusat, DKI Jakarta, Indonesia
    RSCM Kirana
Feb 1, 2021

Venous Leg Ulcer Trial in United States (0.1% TR 987, Placebo gel)

Unknown status
  • Venous Leg Ulcer
  • 0.1% TR 987
  • Placebo gel
  • Los Angeles, California
  • +8 more
Oct 21, 2020

Elevated Blood Pressure Trial in Winnipeg (High molecular weight ß-glucan oat cookies, Control wheat based cookies)

Recruiting
  • Elevated Blood Pressure
  • High molecular weight β-glucan oat cookies
  • Control wheat based cookies
  • Winnipeg, Manitoba, Canada
    Chronic Disease Innovation Centre, Seven Oaks Hospital
Jun 20, 2022

Intra Abdominal Infections, Candidiasis, Invasive, Peritoneal Candidiasis Trial in France (1.3 BETA D GLUCAN)

Unknown status
  • Intra Abdominal Infections
  • +3 more
  • 1.3 BETA D GLUCAN
  • Metz, Lorraine, France
  • +3 more
Feb 20, 2020

Neuroblastoma Trial in New York (beta-glucan, mAb 3F8, immunohistochemistry staining method)

Completed
  • Neuroblastoma
  • beta-glucan
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Mar 4, 2022

Invasive Fungal Infections Trial (procalcitonin ,CRP and 1, 3- ß -D- glucan in early diagnosis of invasive infections)

Not yet recruiting
  • Invasive Fungal Infections
  • procalcitonin ,CRP and 1, 3- β -D- glucan in early diagnosis of invasive infections
  • (no location specified)
Feb 10, 2023

Cardiometabolic Syndrome Trial in Malang (ß-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group,

Enrolling by invitation
  • Cardiometabolic Syndrome
  • β-1,3/1,6-D-Glucan From Mycelia Extract of Indonesia's Ganoderma Lucidum Group
  • Placebo Group
  • Malang, East Java, Indonesia
    General Hospital of Brawijaya University (Rumah Sakit Universita
Oct 3, 2021

Hyperlipidemias Trial in Montreal (CP105F, Placebo)

Completed
  • Hyperlipidemias
  • Montreal, Quebec, Canada
    Montreal Heart Institute
Jan 14, 2022

Invasive Fungal Infection, Hematological Malignancy, Receipt of Solid Organ Transplant Trial in Graz (Fungitell Assay in BAL)

Completed
  • Invasive Fungal Infection
  • +2 more
  • Fungitell Assay in BAL
  • Graz, Styria, Austria
    Medical University of Graz
Sep 22, 2021

Acute Myeloid Leukemia, Myeloid Tumor Trial in Seattle (Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myeloid Neoplasm
  • Biospecimen Collection
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 5, 2023

Type 1 Diabetes Trial in Seattle (Verapamil)

Completed
  • Type 1 Diabetes
  • Seattle, Washington
    Benaroya Research Institute
Apr 27, 2023

Metastatic Pancreatic Adenocarcinoma Trial (odetiglucan, CDX-1140)

Not yet recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • odetiglucan
  • CDX-1140
  • (no location specified)
Jul 29, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Trial in United States

Suspended
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • Los Angeles, California
  • +5 more
Dec 10, 2022

Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone

Not yet recruiting
  • Acute Myeloid Leukemia With KMT2A Rearrangement
  • Acute Myeloid Leukemia With NPM1 Mutation
  • Biospecimen Collection
  • +7 more
  • (no location specified)
Jun 1, 2023

FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • FLT3 Gene Mutation Negative
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +7 more
  • Blinatumomab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2022

Acute Myeloid Leukemia Trial in Nashville (Biopsy of Bone, Cytarabine, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Biospecimen Collection
  • +5 more
  • Buffalo, New York
  • +1 more
Jan 27, 2023

Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients

Not yet recruiting
  • Copd Patients
  • IL B,IL 3 in nasal swap and serum
  • (no location specified)
Aug 4, 2023

Juvenile Idiopathic Arthritis Trial in Amiens (The Juvenile Disease Activity Score (JADAS), (1-3)-ß-D-Glucan (BDG) assay

Unknown status
  • Juvenile Idiopathic Arthritis
  • The Juvenile Disease Activity Score (JADAS)
  • (1-3)-ß-D-Glucan (BDG) assay (Fungitell)
  • Amiens, France
    CHU Amiens
Jun 11, 2019

Acute Myeloid Leukemia Trial in Seattle (drug, biological, other)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 10, 2022

Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia Trial in Seattle (Cladribine, Cytarabine,

Recruiting
  • Acute Biphenotypic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 18, 2022

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 15, 2022

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2022

Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Mixed Phenotype Acute Leukemia

Not yet recruiting
  • Recurrent Acute Leukemia of Ambiguous Lineage
  • +5 more
  • Biospecimen Collection
  • +12 more
  • (no location specified)
Mar 8, 2023